SSC 2026 Guidelines now available — 129 adult & 61 pediatric recommendations View guidelines →
Evidence-based guideline for CLABSI prevention, including insertion and maintenance bundles, supplemental strategies, diagnosis and management of catheter-related bloodstream infections, and surveillance.
CLABSI prevention in neonates, immunocompromised patients, hemodialysis catheters, and long-term catheters; NHSN surveillance methodology; SIR calculation; CUSP framework; daily goals checklist; nurse empowerment; zero CLABSI sustainability.
Antimicrobial-impregnated catheters, antimicrobial lock therapy, CHG-impregnated dressings, antibiotic ointments, diagnosis of CRBSI (paired blood cultures, differential time to positivity, catheter tip culture), empiric therapy, catheter removal vs salvage, duration of therapy by organism, and suppurative thrombophlebitis.
Evidence-based insertion bundle components (hand hygiene, maximal sterile barriers, chlorhexidine antisepsis, site selection, daily necessity review) and maintenance bundle components (hub disinfection, CHG bathing, dressing management, needleless connectors, administration set changes) with supporting evidence.
CLABSI and CRBSI definitions, NHSN surveillance criteria, mucosal barrier injury CLABSI, epidemiology by ICU type, attributable mortality and costs, pathogenesis of catheter colonization, microbiology, and risk factors.
Evidence-based guideline for prevention, recognition, and management of chemotherapy extravasation injuries, including agent classification, antidote protocols, and follow-up care.
Evidence-based guideline for selection, insertion, maintenance, and complication management of central venous access devices in oncology patients, synthesized from multiple professional society recommendations.
Evidence-based guideline for risk assessment, prophylaxis, diagnosis, and treatment of venous thromboembolism in cancer patients, including catheter-related thrombosis.
Pediatric oncology, elderly patients, thrombocytopenic and anticoagulated patients, device removal criteria and procedures, patient and caregiver education, and quality surveillance for CVADs in oncology.
Comprehensive management of central venous access device-related thrombosis including diagnosis, treatment, catheter management decisions, upper extremity DVT, patient education, monitoring, and follow-up.
CLABSI prevention and treatment, catheter-associated thrombosis, occlusion management, extravasation, catheter malposition, pinch-off syndrome, and catheter damage in oncology CVAD patients.
Management of cancer-associated VTE in special populations including brain tumors, thrombocytopenia, renal impairment, GI/GU cancers, recurrent VTE on anticoagulation, incidental and subsegmental PE, and IVC filter indications.
Flushing and locking protocols, dressing change procedures, needleless connector management, port access and deaccess procedures, blood sampling, and patency assessment for CVADs in oncology patients.
Surgical consultation criteria, wound grading, patient follow-up protocols, peripheral vs. central line extravasation management, documentation requirements, incident reporting, legal considerations, staff competency assessment, and institutional protocol development.
Complete treatment protocols for cancer-associated VTE including LMWH dosing, DOAC regimens (rivaroxaban, edoxaban, apixaban), warfarin considerations, duration of anticoagulation, and landmark trial data from SELECT-D, HOKUSAI-VTE Cancer, ADAM-VTE, and CARAVAGGIO.
Insertion site selection, ultrasound-guided placement, tip confirmation, skin antisepsis, dressing and securement, and site care protocols for central venous access devices in oncology patients.
Signs and symptoms of extravasation (early and late), differential diagnosis, step-by-step immediate management algorithm, specific antidote protocols with complete dosing for dexrazoxane, hyaluronidase, sodium thiosulfate, and DMSO, and thermal management by agent class.
Evidence-based recommendations for VTE prophylaxis in ambulatory, hospitalized, and surgical cancer patients, including CVAD-related thrombosis prevention, with complete dosing tables and key trial data.
CVAD types and oncology-specific indications, patient assessment framework, vein selection in cancer patients, device selection algorithms, and special population considerations for central venous access in oncology.
Complete classification of antineoplastic agents by tissue damage potential (vesicants, irritants, non-vesicants), comprehensive risk factor analysis, and evidence-based prevention strategies including vein selection, device selection, and monitoring protocols.
Pathophysiology of cancer-associated thrombosis, Virchow's triad in malignancy, and validated VTE risk assessment models including the Khorana score, Vienna CATS score, PROTECHT score, and ONKOTEV score with complete scoring tables.
What is vascular access? Definitions, clinical context, the full VAD spectrum from peripheral to central, indications for each device type, and who performs vascular access procedures.
The definitive clinical reference on vascular access — device spectrum, evidence-based selection, current clinical standards, complication overview, documentation, and quality metrics for clinicians.
Annual state-of-the-practice safety report for vascular access: national CLABSI rates, PICC complication data, peripheral IV failure rates, phlebitis benchmarks, catheter-related DVT epidemiology, and the current evidence base driving vascular access safety standards.
Comprehensive vascular access device (VAD) competency and credentialing checklist covering peripheral IV, midline, PICC, central venous catheter, and implanted port access — including ultrasound guidance competency, bundle compliance verification, and annual maintenance requirements.
Complete clinical reference on ultrasound-guided vascular access: evidence base, vascular anatomy, technique (short-axis vs long-axis), US-guided PIV, PICC, and CVC insertion, tip confirmation, and credentialing requirements.
Guide to vascular access requirements for parenteral nutrition (PN): central vs peripheral PN access criteria, osmolarity thresholds, PICC vs CVC for TPN, dedicated PN lumen, filtration requirements, administration set change intervals, and DEHP-free requirements.
Comprehensive guide to oncology vascular access: port vs PICC decision-making, chemotherapy central access requirements, vesicant administration, CLABSI prevention in neutropenic patients, power-injectable port selection, and access management across the cancer treatment continuum.
Clinical guide to hemodialysis vascular access: AVF creation and maturation criteria, AV graft cannulation, tunneled dialysis catheter placement and complications, vessel preservation in CKD/ESRD, fistula-first policy, buttonhole vs rope-ladder technique, and catheter-to-fistula transition.
Complete clinical reference on catheter complications: thrombosis, occlusion, phlebitis, infiltration, extravasation, air embolism, malposition, and skin injury — recognition, prevention, and evidence-based management.
This comprehensive guide outlines evidence-based principles of vascular access and infusion therapy across the lifespan, including neonatal, pediatric, obstetric, and geriatric populations. It covers regulatory compliance, ethical practice, device selection, infusion accuracy, and population-specific risks such as DEHP exposure, DIVA management, pregnancy-related hypercoagulability, and geriatric polypharmacy. Designed for clinicians, nurses, and vascular access specialists, this resource supports safe, patient-centered decision-making aligned with current standards of care.
Establishes the foundational principles governing the administration of infusion therapy and the management of vascular access devices across all specialized patient populations, including pediatric, neonatal, obstetric, and geriatric cohorts.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 5: Comprehensive glossary of vascular access terminology and definitions referenced throughout the guidelines.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 4 covering Sections 5–6: Device Maintenance, Complication Identification & Management, and Special Patient Populations.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 3 covering Sections 3–4: Vascular Access Device Selection, Site Selection, and Insertion Techniques including ultrasound guidance.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 2 continuing Section 1 on implementation considerations, barriers, products, bundles, and checklists for vascular access infrastructure.
Association for Vascular Access Adult Clinical Practice Guidelines (JAVA 2026, Vol. 31) — Part 1 covering guideline development, acknowledgments, foreword, introduction, and Sections 1–2: Infrastructure, Teams, Clinical Foundations, and Patient Assessment.
A candid critique of healthcare's resistance to innovation: why vascular access and clinical practice remain stuck in outdated patterns while real problems like CLABSIs persist.
Comprehensive guide to preventing hemolysis during blood draws: understanding catheter-to-vein ratio (CVR), cavitation physics, and evidence-based techniques for optimal lab sample quality.
Comprehensive guide to clinical decision-making in vascular access: exploring interprofessional collaboration, evidence-based protocols, and patient-centered care strategies for optimal outcomes.
Evidence-based clinical guidelines for vascular access device removal: comprehensive protocols for PIVCs, midline catheters, and central lines to optimize patient safety and outcomes.
Comprehensive clinical guideline for Peripheral Arterial Disease (PAD) management in vascular access: evidence-based protocols for assessment, prevention, and treatment strategies.
Establishes requirements for vascular access device selection, technical standards, and maintenance protocols for patients undergoing therapeutic apheresis procedures.
Establishes standards for the access, maintenance, dressing, and patient education requirements for implanted vascular access ports, including noncoring needle selection, flushing protocols, power injection verification, and ongoing device surveillance.
Establishes standards for umbilical arterial catheter (UAC) and umbilical venous catheter (UVC) indications, antisepsis, tip positioning, imaging confirmation, securement, complication surveillance, and removal in neonatal patients.
Evidence-based standards for the clinical evaluation, insertion, management, complication monitoring, and removal of intraosseous vascular access devices across emergent and non-emergent clinical applications in adult and pediatric patients.
Establishes standards for hemodialysis vascular access device selection, vessel health and preservation, access hierarchy, infection prevention, hub care, AVF/AVG cannulation, catheter locking solutions, and patient education for patients receiving or anticipated to receive hemodialysis.
Establishes standards for the selection and application of vascular visualization technology—including ultrasound, near-infrared, and visible light devices—to improve vascular access insertion success and reduce complications across all patient populations.
Establishes evidence-based criteria for the selection and planning of vascular access devices across all device types and patient populations, from short peripheral catheters through central venous access devices and arterial catheters.
Establishes standards for central vascular access device tip location confirmation, including acceptable tip positions, real-time tip location methods, re-evaluation protocols, transfer criteria, and documentation requirements for all patient populations.